These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Borroni B; Archetti S; Alberici A; Agosti C; Gennarelli M; Bigni B; Bonvicini C; Ferrari M; Bellelli G; Galimberti D; Scarpini E; Di Lorenzo D; Caimi L; Caltagirone C; Di Luca M; Padovani A Neurogenetics; 2008 Jul; 9(3):197-205. PubMed ID: 18392865 [TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287 [TBL] [Abstract][Full Text] [Related]
6. Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. Boeve BF; Baker M; Dickson DW; Parisi JE; Giannini C; Josephs KA; Hutton M; Pickering-Brown SM; Rademakers R; Tang-Wai D; Jack CR; Kantarci K; Shiung MM; Golde T; Smith GE; Geda YE; Knopman DS; Petersen RC Brain; 2006 Nov; 129(Pt 11):3103-14. PubMed ID: 17030535 [TBL] [Abstract][Full Text] [Related]
7. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Gass J; Cannon A; Mackenzie IR; Boeve B; Baker M; Adamson J; Crook R; Melquist S; Kuntz K; Petersen R; Josephs K; Pickering-Brown SM; Graff-Radford N; Uitti R; Dickson D; Wszolek Z; Gonzalez J; Beach TG; Bigio E; Johnson N; Weintraub S; Mesulam M; White CL; Woodruff B; Caselli R; Hsiung GY; Feldman H; Knopman D; Hutton M; Rademakers R Hum Mol Genet; 2006 Oct; 15(20):2988-3001. PubMed ID: 16950801 [TBL] [Abstract][Full Text] [Related]
8. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. López de Munain A; Alzualde A; Gorostidi A; Otaegui D; Ruiz-Martínez J; Indakoetxea B; Ferrer I; Pérez-Tur J; Sáenz A; Bergareche A; Barandiarán M; Poza JJ; Zabalza R; Ruiz I; Urtasun M; Fernández-Manchola I; Olasagasti B; Espinal JB; Olaskoaga J; Ruibal M; Moreno F; Carrera N; Martí Massó JF Biol Psychiatry; 2008 May; 63(10):946-52. PubMed ID: 17950702 [TBL] [Abstract][Full Text] [Related]
9. Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN). Gabryelewicz T; Masellis M; Berdynski M; Bilbao JM; Rogaeva E; St George-Hyslop P; Barczak A; Czyzewski K; Barcikowska M; Wszolek Z; Black SE; Zekanowski C J Alzheimers Dis; 2010; 22(4):1123-33. PubMed ID: 20930269 [TBL] [Abstract][Full Text] [Related]
10. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy. Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413 [TBL] [Abstract][Full Text] [Related]
11. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631 [TBL] [Abstract][Full Text] [Related]
17. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Borroni B; Alberici A; Premi E; Archetti S; Garibotto V; Agosti C; Gasparotti R; Di Luca M; Perani D; Padovani A Rejuvenation Res; 2008 Jun; 11(3):585-95. PubMed ID: 18593276 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624 [TBL] [Abstract][Full Text] [Related]
19. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort. Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032 [TBL] [Abstract][Full Text] [Related]
20. Novel progranulin mutation: screening for PGRN mutations in a Portuguese series of FTD/CBS cases. Guerreiro RJ; Santana I; Bras JM; Revesz T; Rebelo O; Ribeiro MH; Santiago B; Oliveira CR; Singleton A; Hardy J Mov Disord; 2008 Jul; 23(9):1269-73. PubMed ID: 18464284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]